Silicon Valley Capital Partners’s Quest Diagnostics DGX Stock Holding History

Silicon Valley Capital Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.17K	Hold	47	–	–	﹤0.01%	221
2025 Q4	$8.08K	Buy	47 +1	+2%	+$182	﹤0.01%	213
2025 Q3	$8.84K	Hold	46	–	–	﹤0.01%	216
2025 Q2	$8.29K	Hold	46	–	–	﹤0.01%	221
2025 Q1	$7.69K	Hold	46	–	–	﹤0.01%	208
2024 Q4	$6.9K	Buy	46 +1	+2%	+$156	﹤0.01%	274
2024 Q3	$7.06K	Hold	45	–	–	﹤0.01%	266
2024 Q2	$6.2K	Hold	45	–	–	﹤0.01%	269
2024 Q1	$5.99K	Buy	+45	New	+$5.84K	﹤0.01%	261

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Silicon Valley Capital Partners's DGX Position: Q1 2026 in Review

Silicon Valley Capital Partners held its Quest Diagnostics (DGX) position steady in Q1 2026 at 47 shares worth $9.17K. The position accounts for ﹤0.01% of the portfolio, ranked #221.

Silicon Valley Capital Partners first reported a position in DGX in Q1 2024 and has held it in 9 quarters since. 1,064 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

Silicon Valley Capital Partners held 47 shares of Quest Diagnostics worth $9.17K as of Q1 2026.
Silicon Valley Capital Partners left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up ﹤0.01% of Silicon Valley Capital Partners's portfolio in Q1 2026, its #221 holding.
Silicon Valley Capital Partners first reported a position in Quest Diagnostics in Q1 2024 and has held it in 9 quarters since.
1,064 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Silicon Valley Capital Partners's 13F filing for Q1 2026, filed 19 May 2026.